Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024

Published on September 12, 2024

This report describes the Advisory Committee on Immunization Practices recommendation for use of the 21-valent pneumococcal conjugate vaccine as an option for some adults.